CECOG Academy

www.cecog.org

 

CECOG Academy
E

SABCS Updates on CDK4/6i in HR+, HER2- EBC: Is It Time to Adopt in Adjuvant Setting?

By CECOG Academy FEATURING Evandro de Azambuja
By CECOG Academy FEATURING Evandro de Azambuja
183 views
March 29, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

08:44
Johnson & Johnson

Management and Proactive Care of Adverse Events Associated with Loca…

Feat. J. Sabari, A. Spira

Featured Video

02:58
Lilly Medical Affairs

A Heterogenous Disease with Varied Clinical Outcomes: HR+/HER2- MBC

Feat. J. O’Shaughnessy
Post SABCS Webinar
25:58

SABCS Updates on Targeting Mutations in MBC Treatment: PIK3CA, AKT &…

CECOG Academy

L. De Mattos-Arruda

124 views
16:33

SABCS Updates on CDK4/6i in HR+, HER2- EBC: Is It Time to Adopt in A…

CECOG Academy

E. de Azambuja

183 views
15:56

Immune CPIs in mTNBC: What, When and Where?

CECOG Academy

E. de Azambuja

131 views
25:24

SABCS Updates on TNBC: Chemotherapy, Biomarkers, PARPi, AKTi, CDK4/6…

CECOG Academy

R. Bartsch

184 views